Supplementary Data from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)